Health
Research into COVID treatments catching up – Esperance Express
Australia has closed a deal for 300,000 courses of an antiviral pill showing promising signs of slashing COVID-19 deaths and…
Australia has closed a deal for 300,000 courses of an antiviral pill showing promising signs of slashing COVID-19 deaths and hospitalisations.
Molnupiravir is still being trialled in the US and is yet to gain regulatory authorisation.
But the federal government…
Continue Reading
-
Noosa News23 hours agoLightning, hail and deluges thrashing Qld and NSW
-
General17 hours agoThree players sin-binned as Australia win torrid second Test 14-4 over England to retain Ashes
-
General23 hours agoMelbourne Cup 2025 field, horses, form guide and betting
-
General22 hours agoWe will repeal the treaty within 100 days!